Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repaglinide and Metformin Combination vs Repaglinide Monotherapy in Chinese OAD Naive T2D
NCT00819741Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Feb 2009
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of repaglinide in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Feb 2009; status: completed.
02
Drugs
repaglinide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00819741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00819741.